Clinical Trial: A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)
Study Status: Completed
Recruit Status: RECRUITING
Condition: Non-alcoholic Steatohepatitis
Study Type: INTERVENTIONAL
Official Title: An Open-Label, Single-Dose Study to Evaluate the Pharmacokinetics of Efinopegdutide (MK-6024) in Participants With Moderate and Severe Hepatic Impairment
Brief Summary:
The purpose of this study is to evaluate the pharmacokinetics of efinopegdutide in participants with hepatic impairment compared to healthy participants, and to examine the safety and tolerability of efinopegdutide.
Read more